Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
From genetic associations to functional studies in multiple sclerosis.
Interferon β-1a and Atorvastatin in the Treatment of Multiple Sclerosis.
Intrathecal gene therapy rescues a model of demyelinating peripheral neuropathy.
Natalizumab: A Review of Its Use in the Management of Relapsing-Remitting Multiple Sclerosis.
2'-Hydroxy ceramide in membrane homeostasis and cell signaling.
The effect of fluoxetine on progression in progressive multiple sclerosis: a double-blind, randomized, placebo-controlled trial.
Immunoregulatory Effects of Interferon-β in Suppression of Th17 cells.
Myelin alters the inflammatory phenotype of macrophages by activating PPARs.
Antibodies identified by cell-based assays in myasthenia gravis and associated diseases.
Intractable vomiting as an initial presentation of lupus-related neuromyelitis optica.
Inflammatory macrophage migration in experimental autoimmune encephalomyelitis.
Immune surveillance of the central nervous system in multiple sclerosis - Relevance for therapy and experimental models.
A modality-agnostic patch-based technique for lesion filling in multiple sclerosis.
Common gut microbe could help prevent development of multiple sclerosis.
Adenosine 2A receptor agonism: A single intrathecal administration attenuates motor paralysis in experimental autoimmune encephalopathy in rats.
Presentation of multiple sclerosis with comorbid Huntington's disease.
Psychosocial difficulties from the perspective of persons with neuropsychiatric disorders.
Variants of MicroRNA Genes: Gender-Specific Associations with Multiple Sclerosis Risk and Severity.
Comments on the review article 'Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades'.
Helminth Products Protect against Autoimmunity via Innate Type 2 Cytokines IL-5 and IL-33, Which Promote Eosinophilia.
The Effects of Co-transplantation of Olfactory Ensheathing Cells and Schwann Cells on Local Inflammation Environment in the Contused Spinal Cord of Rats.
Medical Tourism for CCSVI Procedures in People with Multiple Sclerosis: An Observational Study.
Toll-like receptor signalling as a cannabinoid target in Multiple Sclerosis.
Vitamin D: A Narrative Review Examining the Evidence for Ten Beliefs.
Evaluation of contrast sensitivity measurements after retrobulbar optic neuritis in Multiple Sclerosis.
Pages
« first
‹ previous
…
615
616
617
618
619
620
621
622
623
…
next ›
last »